VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CHWY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CHWYChewy, Inc.
$20.73$8.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCHWYFinancials

Chewy, Inc. (CHWY) Financials

10Y historyFree accessUpdated daily

Revenue growth has decelerated to 4.8% in 2026Q1, while operating margins remain constrained at 1.3% due to persistent SG&A expenses.

CHWY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMFeb'26Jan'25Jan'24Jan'23Jan'22Jan'21Jan'20Jan'19Jan'18Jan'17
Sales/Revenue12.75B12.6B11.86B11.15B10.12B8.97B7.15B4.85B3.53B2.1B900.57M
Revenue Growth %2.1%6.24%6.4%10.17%12.84%25.48%47.44%37.19%67.89%133.66%-
Cost of Goods Sold8.96B8.85B8.39B7.99B7.28B6.58B5.33B3.7B2.82B1.74B750.74M
COGS % of Revenue-70.21%70.76%71.64%71.99%73.4%74.52%76.4%79.77%82.53%83.36%
Gross Profit3.79B3.75B3.47B3.16B2.83B2.39B1.82B1.14B714.8M367.55M149.83M
Gross Margin %29.72%29.79%29.24%28.36%28.01%26.6%25.48%23.6%20.23%17.47%16.64%
Gross Profit Growth %-8.25%9.68%11.54%18.82%31.01%59.15%60.05%94.48%145.31%-
Operating Expenses3.57B3.5B3.36B3.19B2.78B2.46B1.91B1.4B982.57M705.4M257.26M
OpEx % of Revenue-27.77%28.29%28.57%27.45%27.42%26.75%28.82%27.81%33.52%28.57%
Selling, General & Admin3.57B3.5B3.36B3.19B2.78B2.46B1.91B1.4B982.57M705.4M257.26M
SG&A % of Revenue-27.77%28.29%28.57%27.45%27.42%26.75%28.82%27.81%33.52%28.57%
Research & Development0037.6M30.2M22.4M14.2M7.4M0000
R&D % of Revenue--0.32%0.27%0.22%0.16%0.1%----
Other Operating Expenses00-37.6M-30.2M-22.4M-14.2M-7.4M0000
Operating Income219.9M254.3M112.59M-23.63M56.42M-73.57M-90.46M-252.73M-267.77M-337.85M-107.43M
Operating Margin %1.72%2.02%0.95%-0.21%0.56%-0.82%-1.27%-5.21%-7.58%-16.06%-11.93%
Operating Income Growth %-125.87%576.56%-141.87%176.69%18.68%64.2%5.62%20.74%-214.49%-
EBITDA356.2M383.6M227.14M86.07M139.86M-18.25M-54.8M-222.08M-244.56M-325.31M-102.38M
EBITDA Margin %2.79%3.04%1.92%0.77%1.38%-0.2%-0.77%-4.58%-6.92%-15.46%-11.37%
EBITDA Growth %77.81%68.88%163.91%-38.46%866.49%66.7%75.32%9.19%24.82%-217.74%-
D&A (Non-Cash Add-back)136.3M129.3M114.56M109.69M83.44M55.32M35.66M30.64M23.21M12.54M5.04M
EBIT232.1M267.9M157.21M51.81M55.12M-73.04M-90.46M-252.73M-267.77M-337.85M-106.87M
Net Interest Income14.8M15.2M35.07M58.5M9.29M-1.64M-2.02M356K-124K-206K222K
Interest Income19.4M19.8M40.59M62.08M11.87M523K0356K57K350K518K
Interest Expense4.6M4.6M5.52M3.58M2.58M2.16M2.02M0181K556K296K
Other Income/Expense7.6M9M39.11M71.86M-3.88M-1.64M-2.02M356K-124K-206K263K
Pretax Income227.5M263.3M151.69M48.23M52.55M-75.21M-92.49M-252.37M-267.89M-338.06M-107.16M
Pretax Margin %1.78%2.09%1.28%0.43%0.52%-0.84%-1.29%-5.21%-7.58%-16.07%-11.9%
Income Tax27.9M40.5M-241.04M8.65M2.65M000000
Effective Tax Rate %12.26%15.38%-158.9%17.93%5.04%0%0%0%0%0%0%
Net Income199.6M222.8M392.74M39.58M49.9M-75.21M-92.49M-252.37M-267.89M-338.06M-107.16M
Net Margin %1.57%1.77%3.31%0.36%0.49%-0.84%-1.29%-5.21%-7.58%-16.07%-11.9%
Net Income Growth %78.35%-43.27%892.26%-20.68%166.35%18.68%63.35%5.79%20.76%-215.46%-
Net Income (Continuing)199.6M222.8M392.74M39.58M49.9M-75.21M-92.49M-252.37M-267.89M-338.06M-107.16M
Discontinued Operations00000000000
Minority Interest00000000000
EPS (Diluted)0.470.520.910.090.12-0.18-0.23-0.63-0.68-0.85-0.27
EPS Growth %72.54%-42.86%893.45%-23.67%166.67%21.74%63.49%7.35%20%-214.81%-
EPS (Basic)-0.530.930.090.12-0.18-0.23-0.63-0.68-0.85-0.27
Diluted Shares Outstanding424.1M425.8M430.99M432.04M427.77M417.22M407.24M401.37M395.71M395.71M395.71M
Basic Shares Outstanding414.4M414.1M421.35M429.46M422.33M417.22M407.24M401.37M393M395.71M395.71M
Dividend Payout Ratio-----------

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Stagnating Active Customer Base

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Top Line Growth Faces Headwinds

As reported in recent financial filings, Chewy's revenue growth has decelerated to 4.8% in 2026Q1, marking a significant departure from the double-digit expansion observed in prior periods and highlighting the challenges of maintaining scale in a saturated e-commerce pet consumables market.

The transition from high-growth expansion to low-single-digit revenue increases suggests that the company is struggling to acquire new customers at historical rates. Investors should monitor whether this deceleration reflects a permanent shift in market penetration or a temporary pause in consumer discretionary spending on non-essential pet goods.

Structural Constraints Limit Margin Expansion

Based on the company's reported figures, gross margins have remained tightly clustered around the 29-30% range over the last ten quarters, indicating that competitive pricing pressures and high fulfillment costs continue to act as a ceiling on profitability.

Despite the shift toward higher-margin pharmacy and health services, the lack of meaningful gross margin expansion suggests that the core consumables business remains highly sensitive to logistics costs. This persistent margin profile implies that significant operational leverage may be difficult to achieve without a fundamental change in the product mix.

Operating Leverage Remains Elusive

According to quarterly income statements, operating margins have compressed to 1.3% in 2026Q1, demonstrating that SG&A expenses are scaling in lockstep with gross profit and preventing the company from realizing meaningful bottom-line operating leverage.

The inability to decouple operating expenses from revenue growth suggests that the company's fulfillment and marketing infrastructure requires constant reinvestment to maintain its competitive position. This trend warrants further investigation into whether the current cost structure is inherently inefficient or if it reflects a strategic choice to prioritize market share over immediate profitability.

Stock-Based Compensation Masks True Profitability

As evidenced by the provided data, share-based compensation remains a substantial recurring expense, frequently exceeding $60 million per quarter, which significantly distorts the quality of GAAP net income and complicates the assessment of the company's underlying cash-generating capability.

The reliance on equity-based incentives to manage cash outflows appears to be a structural feature of the company's compensation model, which may be masking the true cost of talent acquisition. Investors should be cautious when evaluating EPS growth, as the dilution and non-cash nature of these expenses often create a disconnect between reported earnings and actual free cash flow.

Saturation Risks Challenge Growth Narrative

Based on the stagnation of revenue growth and the thin operating margins reported in recent filings, short-sellers may argue that the company has reached a maturity phase where the cost of customer acquisition outweighs the lifetime value of the remaining addressable market.

The reliance on a stagnant active customer base to drive future earnings growth appears increasingly fragile, particularly if the company cannot successfully pivot to higher-margin services. This scenario suggests that the market may be overestimating the company's ability to extract more value from existing customers without incurring prohibitive marketing or operational costs.

CHWY — Frequently Asked Questions

Quick answers to the most common questions about buying CHWY stock.

What was Chewy, Inc.'s (CHWY) revenue in 2025?

For fiscal year 2025, Chewy, Inc. (CHWY) reported total revenue of $12.60B. This represents a 1299.3% increase compared to $900.6M in 2016.

Is Chewy, Inc. (CHWY) profitable?

Chewy, Inc. (CHWY) is profitable, generating $222.8M in net income for the fiscal year ending 2025 with a net profit margin of 1.8%.

What is Chewy, Inc.'s operating profit margin?

Chewy, Inc. (CHWY) reported an operating income of $254.3M, resulting in an operating profit margin of 2.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Chewy, Inc.'s gross profit and gross margin?

Chewy, Inc. (CHWY) generated $3.75B in gross profit for the year, representing a gross profit margin of 29.8%. This demonstrates the company's core pricing power and production efficiency.